Stefanie Steiger (@stefaniesteige6) 's Twitter Profile
Stefanie Steiger

@stefaniesteige6

Group Leader at the LMU Hospital in Munich. Interest in nephrology, hyperuricemia, uric acid, inflammation, infection, immune cells, and crystal biology.

ID: 1280838147685912578

linkhttps://www.kidney-immunology-lab-munich.de calendar_today08-07-2020 12:17:05

161 Tweet

166 Followers

93 Following

Andreas Kronbichler (@akronbichler) 's Twitter Profile Photo

SGLT2i are highly effective drugs to prevent progression of CKD. However, several populations at risk (also to have CV events) are excluded from trials; also now that combination therapies are tested. A summary of my talk on SGLT2i and autoimmunity: sciencedirect.com/science/articl…

SGLT2i are highly effective drugs to prevent progression of CKD. However, several populations at risk (also to have CV events) are excluded from trials; also now that combination therapies are tested. A summary of my talk on SGLT2i and autoimmunity: sciencedirect.com/science/articl…
ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

💡Submit your Late Breaking Clinical Trial and take innovation beyond nephrology at the cutting edge of research at #ERA25!⁣ 🎙️The best Abstracts will be selected for presentation at the LBCT Symposium ⁣ ⏰Deadline: March 26, 2025 Submit now 👉 lc.cx/aBn6pl

💡Submit your Late Breaking Clinical Trial and take innovation beyond nephrology at the cutting edge of research at #ERA25!⁣
🎙️The best Abstracts will be selected for presentation at the LBCT Symposium ⁣
⏰Deadline: March 26, 2025
Submit now 👉 lc.cx/aBn6pl
Alex Weber, immunologist researcher in Tübingen (@innate_immuno) 's Twitter Profile Photo

📢the program for #NCII 2025 #conference in #immunology (incl. #Inflammasome, #TLR, #cancer, #macrophage, #microbiota) is now online - check it out at innate-immunity-conference.de! Make sure to submit #abstracts to compete for oral talk slots and great prizes🥇

📢the program for #NCII 2025 #conference in #immunology (incl. #Inflammasome, #TLR, #cancer, #macrophage, #microbiota) is now online - check it out at innate-immunity-conference.de! Make sure to submit #abstracts to compete for oral talk slots and great prizes🥇
Soehnlein Lab (@soehnleinlab) 's Twitter Profile Photo

Not all plaques are the same. Check out our latest review in EHJ Editor-in-Chief to learn why this is. Great joint effort with Esther Lutgens and Yvonne Döring. #inflammation #atherosclerosis academic.oup.com/eurheartj/adva…

ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

⏳ LAST HOURS TO JOIN THE OFFICIAL ERA WORKING GROUPS!⁣ 🚀 Don't miss the chance to actively contribute to developing research and education activities in different areas of nephrology. Apply NOW 👉 lc.cx/wqpXMH

⏳ LAST HOURS TO JOIN THE OFFICIAL ERA WORKING GROUPS!⁣
🚀 Don't miss the chance to actively contribute to developing research and education activities in different areas of nephrology.
Apply NOW 👉 lc.cx/wqpXMH
ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

📢 Join us at the ERA Journal Club e-seminar! *Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)* 📅 April 24, 2025, 6:00 PM (CEST) 🆕The live e-seminars are now real-time

📢 Join us at the ERA Journal Club e-seminar!
*Disease-modifying anti-nephropathic drugs (DMANDs) – A definition proposed by the Immunonephrology Working Group (IWG) of the European Renal Association (ERA)*
📅 April 24, 2025, 6:00 PM (CEST)
🆕The live e-seminars are now real-time
Andreas Kronbichler (@akronbichler) 's Twitter Profile Photo

It is of importance to us to understand the habits of physicians to use anticoagulation in nephrotic syndrome. Please spend 5 minutes to answer some pressing questions including the potential role or aspirin! The Link is posted below: qualtricsxm564785h8t.qualtrics.com/jfe/form/SV_7O…

ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

📣 Save the date! Symposium 2.4 at #ERA25 will focus on "Game changers in Kidney Vasculitis", join our speakers on 📅June 5, 8:15 - 9:45 (CEST) Discover our Scientific Programme 👉 bit.ly/41UFxSo

📣 Save the date! Symposium 2.4 at #ERA25 will focus on "Game changers in Kidney Vasculitis", join our speakers on
📅June 5, 8:15 - 9:45 (CEST)
Discover our Scientific Programme 👉 bit.ly/41UFxSo
Berci Meskó, MD, PhD (@berci) 's Twitter Profile Photo

In less than 6 months, scientists could use the CRISPR gene-editing technique to improve a newborn's genetic condition. I wanted to write about the details, but I notice something. Every peer-reviewed paper about the case in NEJM and every major news channel or magazine covering

In less than 6 months, scientists could use the CRISPR gene-editing technique to improve a newborn's genetic condition. I wanted to write about the details, but I notice something.

Every peer-reviewed paper about the case in NEJM and every major news channel or magazine covering
NDT (@ndtsocial) 's Twitter Profile Photo

Complement activation in secondary thrombotic microangiopathies doi.org/10.1093/ndt/gf… This Review summarizes the current understanding and future directions in the management of secondary TMA, emphasizing the potential of complement inhibition as therapeutic strategy

Complement activation in secondary thrombotic microangiopathies

doi.org/10.1093/ndt/gf…

This Review summarizes the current understanding and future directions in the management of secondary TMA, emphasizing the potential of complement inhibition as therapeutic strategy
Alex Weber, immunologist researcher in Tübingen (@innate_immuno) 's Twitter Profile Photo

#Immunologists, only less than 2 weeks left to register for our #conference Novel Concepts in Innate Immunity (#NCII) 2025 starting 10 June. Sign up NOW for the latest #research in #immunology, great speakers, exciting abstracts, interactions with editors and industry!

#Immunologists, only less than 2 weeks left to register for our #conference Novel Concepts in Innate Immunity (#NCII) 2025 starting 10 June. Sign up NOW for the latest #research in #immunology, great speakers, exciting abstracts, interactions with editors and industry!
ERA - European Renal Association (@erakidney) 's Twitter Profile Photo

📣 Save the date! The Opening Lecture at #ERA25 will focus on "A new classification for podocytopathies", join Paola Romagnani on 📅June 4, 8:00 - 8:45 (CEST) Discover our Scientific Programme 👉 bit.ly/41UFxSo

📣 Save the date! The Opening Lecture at #ERA25 will focus on "A new classification for podocytopathies", join Paola Romagnani on
📅June 4, 8:00 - 8:45 (CEST)

Discover our Scientific Programme 👉 bit.ly/41UFxSo
Hans-Joachim Anders (@hjanders_hans) 's Twitter Profile Photo

Now open access in the June edition of NDT Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by the IWG of ERA 🧐Not all drugs that reduce UPCR may be disease-modifying. SGLT2i are a DMAND only for GN-related CKD. academic.oup.com/ndt/article/40…

Now open access in the June edition of <a href="/NDTsocial/">NDT</a>

Disease-modifying anti-nephropathic drugs (DMANDs)—a definition proposed by the IWG of ERA 

🧐Not all drugs that reduce UPCR may be disease-modifying. SGLT2i are a DMAND only for GN-related CKD.

academic.oup.com/ndt/article/40…
Johann Morelle (@johannmorelle) 's Twitter Profile Photo

#Complement Activation in Secondary Thrombotic Microangiopathies (#TMA) ✅ Final version available in #OpenAccess in NDT ➡️ academic.oup.com/ndt/advance-ar… 🙏 experts, colleagues and friends; the ERA - European Renal Association Immunonephrology Working Group; and Andreas Kronbichler for your leadership!

#Complement Activation in Secondary Thrombotic Microangiopathies (#TMA)

✅ Final version available in #OpenAccess in <a href="/NDTsocial/">NDT</a>

➡️ academic.oup.com/ndt/advance-ar…

🙏 experts, colleagues and friends; the <a href="/ERAkidney/">ERA - European Renal Association</a> Immunonephrology Working Group; and <a href="/AKronbichler/">Andreas Kronbichler</a> for your leadership!